FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
Foundation Robotics co-founder Michael LeBlanc explains how humanoid robots are moving from the lab to military and industrial missions and what comes next.